These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9850046)

  • 41. HER-2/neu amplification by fluorescence in situ hybridization in cytologic samples from distant metastatic sites of breast carcinoma.
    Bozzetti C; Personeni N; Nizzoli R; Guazzi A; Flora M; Bassano C; Negri F; Martella E; Naldi N; Franciosi V; Cascinu S
    Cancer; 2003 Oct; 99(5):310-5. PubMed ID: 14579298
    [TBL] [Abstract][Full Text] [Related]  

  • 42. HER-2/neu (c-erb-B2) gene and protein in breast cancer.
    Ross JS; Fletcher JA
    Am J Clin Pathol; 1999 Jul; 112(1 Suppl 1):S53-67. PubMed ID: 10396301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Absence of HER2 overexpression in metastatic malignant melanoma.
    Inman JL; Kute T; White W; Pettenati M; Levine EA
    J Surg Oncol; 2003 Oct; 84(2):82-8. PubMed ID: 14502781
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fine needle aspiration as a tool to establish primary human breast cancer cultures in vitro.
    Araujo RW; Paiva V; Gartner F; Amendoeira I; Oliveira JM; Schmitt FC
    Acta Cytol; 1999; 43(6):985-90. PubMed ID: 10578968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection and temporal appearance of multiple copies of c-erb-B2 genes in advanced mammary carcinoma using fine needle biopsies and the polymerase chain reaction.
    Lönn U; Lönn S; Nylen U; Stenkvist B; Vennström B
    Breast Cancer Res Treat; 1992; 23(3):191-200. PubMed ID: 1463858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Tumor cell dyscohesion in carcinoma of the breast.
    van Diest PJ
    Am J Clin Pathol; 1998 Nov; 110(5):695. PubMed ID: 9802356
    [No Abstract]   [Full Text] [Related]  

  • 47. Calcitriol restores antiestrogen responsiveness in estrogen receptor negative breast cancer cells: a potential new therapeutic approach.
    Santos-Martínez N; Díaz L; Ordaz-Rosado D; García-Quiroz J; Barrera D; Avila E; Halhali A; Medina-Franco H; Ibarra-Sánchez MJ; Esparza-López J; Camacho J; Larrea F; García-Becerra R
    BMC Cancer; 2014 Mar; 14():230. PubMed ID: 24678876
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Astemizole synergizes calcitriol antiproliferative activity by inhibiting CYP24A1 and upregulating VDR: a novel approach for breast cancer therapy.
    García-Quiroz J; García-Becerra R; Barrera D; Santos N; Avila E; Ordaz-Rosado D; Rivas-Suárez M; Halhali A; Rodríguez P; Gamboa-Domínguez A; Medina-Franco H; Camacho J; Larrea F; Díaz L
    PLoS One; 2012; 7(9):e45063. PubMed ID: 22984610
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Immutable functional attributes of histologic grade revealed by context-independent gene expression in primary breast cancer cells.
    Dairkee SH; Sayeed A; Luciani G; Champion S; Meng Z; Jakkula LR; Feiler HS; Gray JW; Moore DH
    Cancer Res; 2009 Oct; 69(19):7826-34. PubMed ID: 19789341
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A molecular 'signature' of primary breast cancer cultures; patterns resembling tumor tissue.
    Dairkee SH; Ji Y; Ben Y; Moore DH; Meng Z; Jeffrey SS
    BMC Genomics; 2004 Jul; 5(1):47. PubMed ID: 15260889
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Culture models of human mammary epithelial cell transformation.
    Stampfer MR; Yaswen P
    J Mammary Gland Biol Neoplasia; 2000 Oct; 5(4):365-78. PubMed ID: 14973382
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Breast cancer cell lines: friend or foe?
    Burdall SE; Hanby AM; Lansdown MR; Speirs V
    Breast Cancer Res; 2003; 5(2):89-95. PubMed ID: 12631387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Origin of cells cultured in vitro from human breast carcinomas traced by cyclin D1 and HER2/neu FISH signal numbers.
    Matouskova E; Kudlackova I; Chaloupkova A; Brozova M; Netikova I; Vesely P
    Anticancer Res; 2005; 25(2A):1051-7. PubMed ID: 15868945
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Her-2/neu evaluation in Sister Mary Joseph's nodule from breast carcinoma: a case report and review of the literature.
    Brunelli M; Manfrin E; Miller K; Eccher A; Gobbo S; Reghellin D; Chilosi M; Remo A; Martignoni G; Menestrina F; Bonetti F
    J Cutan Pathol; 2009 Jun; 36(6):702-5. PubMed ID: 19515052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Propagation of genetically altered tumor cells derived from fine-needle aspirates of primary breast carcinoma.
    Li Z; Bustos V; Miner J; Paulo E; Meng ZH; Zlotnikov G; Ljung BM; Dairkee SH
    Cancer Res; 1998 Dec; 58(23):5271-4. PubMed ID: 9850046
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma.
    Gong Y; Booser DJ; Sneige N
    Cancer; 2005 May; 103(9):1763-9. PubMed ID: 15786420
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Partial enzymatic degradation of stroma allows enrichment and expansion of primary breast tumor cells.
    Dairkee SH; Paulo EC; Traquina P; Moore DH; Ljung BM; Smith HS
    Cancer Res; 1997 Apr; 57(8):1590-6. PubMed ID: 9108465
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.